Takaisin Tulosta

Lasten lääkehoidon indikaatiot ja toteutus

Lisätietoa aiheesta
Matti Salo


  1. de Jongh S, Lilien MR, op't Roodt J ym. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 2002;40:2117-21 «PMID: 12505222»PubMed
  2. Rodenburg J, Vissers MN, Wiegman A ym. Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation 2007;116:664-8 «PMID: 17664376»PubMed
  3. Kusters DM, Avis HJ, de Groot E ym. Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia. JAMA 2014;312:1055-7 «PMID: 25203086»PubMed
  4. Braamskamp MJ, Hutten BA, Wiegman A. Early initiation of statin treatment in children with familial hypercholesterolaemia. Curr Opin Lipidol 2015;26:236-9 «PMID: 25943840»PubMed
  5. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents., National Heart, Lung, and Blood Institute.. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011;128 Suppl 5:S213-56 «PMID: 22084329»PubMed
  6. Wiegman A, Gidding SS, Watts GF ym. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J 2015;36:2425-37 «PMID: 26009596»PubMed
  7. Catapano AL, Graham I, De Backer G ym. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016;37:2999-3058 «PMID: 27567407»PubMed
  8. Wiegman A, Hutten BA, de Groot E ym. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004;292:331-7 «PMID: 15265847»PubMed
  9. McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 2003;143:74-80 «PMID: 12915827»PubMed
  10. Vuorio A, Kuoppala J, Kovanen PT ym. Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev 2010;:CD006401 «PMID: 20614444»PubMed
  11. McCrindle BW, Urbina EM, Dennison BA ym. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007;115:1948-67 «PMID: 17377073»PubMed
  12. Stein EA, Illingworth DR, Kwiterovich PO Jr ym. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 1999;281:137-44 «PMID: 9917116»PubMed
  13. de Jongh S, Ose L, Szamosi T ym. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 2002;106:2231-7 «PMID: 12390953»PubMed
  14. Miller ML, Wright CC, Browne B. Lipid-lowering medications for children and adolescents. J Clin Lipidol 2015;9:S67-76 «PMID: 26343214»PubMed
  15. Joyce NR, Zachariah JP, Eaton CB ym. Statin Use and the Risk of Type 2 Diabetes Mellitus in Children and Adolescents. Acad Pediatr 2017;17:515-522 «PMID: 28232259»PubMed
  16. Vuorio AF, Gylling H, Turtola H ym. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation. Arterioscler Thromb Vasc Biol 2000;20:500-6 «PMID: 10669649»PubMed
  17. Stein EA, Marais AD, Szamosi T ym. Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia. J Pediatr 2010;156:231-6.e1-3 «PMID: 19879596»PubMed
  18. Clauss S, Wai KM, Kavey RE ym. Ezetimibe treatment of pediatric patients with hypercholesterolemia. J Pediatr 2009;154:869-72 «PMID: 19230898»PubMed